Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $300,851 |
Sells | 30 | $2,245,339 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Feb 2025 16:25 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, FINANCE AND CAO | 19 Feb 2025 | Sale | 550 | 1.1502 | 633 | D |
21 Feb 2025 16:23 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 19 Feb 2025 | Sale | 1,326 | 1.1502 | 1,525 | D |
21 Feb 2025 16:20 | ALXO | ALX ONCOLOGY HOLDINGS INC | LETTMANN JASON | CHIEF EXECUTIVE OFFICER | 19 Feb 2025 | Sale | 2,159 | 1.1502 | 2,483 | D |
08 Jan 2025 16:10 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | Interim CFO | 06 Jan 2025 | Sale | 2,221 | 1.8 | 3,998 | D |
02 Jan 2025 16:46 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | Interim CFO | 30 Dec 2024 | Sale | 1,426 | 1.5802 | 2,253 | D |
02 Jan 2025 16:43 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 30 Dec 2024 | Sale | 10,796 | 1.5802 | 17,060 | D |
04 Dec 2024 16:17 | ALXO | ALX ONCOLOGY HOLDINGS INC | HEMRAJANI REKHA | Director | 02 Dec 2024 | Purchase | 30,000 | 1.5468 | 46,404 | D |
16 Aug 2024 17:10 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, FINANCE AND CAO | 14 Aug 2024 | Sale | 564 | 2.58 | 1,455 | D |
16 Aug 2024 17:09 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | CHIEF MEDICAL OFFICER | 14 Aug 2024 | Sale | 1,365 | 2.58 | 3,522 | D |
16 Aug 2024 17:06 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 14 Aug 2024 | Sale | 1,937 | 2.58 | 4,997 | D |
15 Jul 2024 16:06 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 11 Jul 2024 | Sale | 20,000 | 7.9038 | 158,076 | D |
09 Jul 2024 16:09 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, FINANCE AND CAO | 05 Jul 2024 | Sale | 1,823 | 5.4993 | 10,025 | D |
03 Jul 2024 17:03 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, FINANCE AND CAO | 01 Jul 2024 | Sale | 1,373 | 5.8188 | 7,989 | D |
03 Jul 2024 17:02 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | CHIEF MEDICAL OFFICER | 01 Jul 2024 | Sale | 3,273 | 5.8188 | 19,045 | D |
03 Jul 2024 17:00 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 01 Jul 2024 | Sale | 10,758 | 5.8188 | 62,599 | D |
24 Jun 2024 09:00 | ALXO | ALX ONCOLOGY HOLDINGS INC | GARCIA PETER S | CHIEF FINANCIAL OFFICER | 13 Jun 2024 | Purchase A | 12,000 | 8.5282 | 102,338 | D |
17 Jun 2024 07:29 | ALXO | ALX ONCOLOGY HOLDINGS INC | GARCIA PETER S | CHIEF FINANCIAL OFFICER | 13 Jun 2024 | Purchase | 12,000 | 8.5282 | 102,338 | D |
06 Jun 2024 16:06 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 04 Jun 2024 | Sale | 20,000 | 8.4326 | 168,652 | D |
15 May 2024 16:30 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | CHIEF MEDICAL OFFICER | 13 May 2024 | Sale | 1,797 | 16.6716 | 29,959 | D |
15 May 2024 16:30 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | CHIEF MEDICAL OFFICER | 13 May 2024 | Sale | 10,203 | 15.8169 | 161,380 | D |
08 May 2024 17:31 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 06 May 2024 | Sale | 20,000 | 15.9167 | 318,334 | D |
18 Apr 2024 16:49 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 16 Apr 2024 | Sale | 50,000 | 14.2039 | 710,195 | D |
05 Apr 2024 17:37 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | PRESIDENT & CSO | 04 Apr 2024 | Sale | 20,000 | 11.1518 | 223,036 | D |
18 Mar 2024 16:06 | ALXO | ALX ONCOLOGY HOLDINGS INC | LETTMANN JASON | CHIEF EXECUTIVE OFFICER | 14 Mar 2024 | Purchase | 4,400 | 11.3117 | 49,771 | D |
05 Jan 2024 16:03 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, Finance and CAO | 04 Jan 2024 | Sale | 2,717 | 13.602 | 36,957 | D |
03 Jan 2024 16:28 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | SVP, Finance and CAO | 29 Dec 2023 | Sale | 1,631 | 15.04 | 24,530 | D |
03 Jan 2024 16:25 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | Chief Medical Officer | 29 Dec 2023 | Sale | 3,128 | 15.04 | 47,045 | D |
03 Jan 2024 16:20 | ALXO | ALX ONCOLOGY HOLDINGS INC | GARCIA PETER S | Chief Financial Officer | 29 Dec 2023 | Sale | 1,893 | 15.04 | 28,471 | D |
03 Jan 2024 16:17 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | President & CSO | 29 Dec 2023 | Sale | 7,179 | 15.04 | 107,972 | D |
07 Jul 2023 16:09 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | VP, Finance and CAO | 06 Jul 2023 | Sale | 7,345 | 6.52 | 47,889 | D |
05 Jul 2023 17:09 | ALXO | ALX ONCOLOGY HOLDINGS INC | RANDOLPH SOPHIA | Chief Medical Officer | 30 Jun 2023 | Sale | 1,605 | 7.34 | 11,781 | D |
05 Jul 2023 17:07 | ALXO | ALX ONCOLOGY HOLDINGS INC | PONS JAUME | President & CEO | 30 Jun 2023 | Sale | 3,208 | 7.34 | 23,547 | D |
05 Jul 2023 17:05 | ALXO | ALX ONCOLOGY HOLDINGS INC | PINTO SHELLY | VP, Finance and CAO | 30 Jun 2023 | Sale | 466 | 7.34 | 3,420 | D |
05 Jul 2023 17:00 | ALXO | ALX ONCOLOGY HOLDINGS INC | GARCIA PETER S | Chief Financial Officer | 30 Jun 2023 | Sale | 887 | 7.34 | 6,511 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)